Samsung Biologics

About

Company description

Samsung Biologics provides one-stop service from cell-line development, process development, Tox & Clinical material, and commercial manufacturing of Drug Substancee & Drug Product at the same site.

Quick facts

Affiliated categories: Contract Manufacturing |Contract Services - Contract Services |Contract Services - Pre Clinical Trials, Clinical Trials Stages 1-4, CRO, Clinical Data More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 4H27 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 120D02 See our Exhibitor Profile   See full Exhibitor List

News about Samsung Biologics

Samsung Biologics agrees development contract with STCube for anti-cancer candidate

3 Mar 2020

Samsung Biologics agrees development contract with STCube for anti-cancer candidate

Samsung Biologics has signed a development and manufacturing service agreement with local biotech firm, STCube, for the latter’s anti-cancer drug candidate, STT-003, the South Korean CDMO said Tuesday.

Read more

21 Feb 2020

Samsung Biologics reassures clients as South Korean coronavirus cases grow

South Korea’s Samsung Biologics has sought to reassure clients that it is business as usual at the contract development and manufacturing organisation (CDMO) as the number of confirmed coronavirus (COVID-19) infections in the country continues to soar.

Read more
Samsung Biologics

Contact information

Address

Telephone

Website

View all contact information